List of 2023 Speakers

Confirmed Speakers Joining Us This Year

Steve Bartz

Vice President Corporate Development, Seattle Genetics

Alex Burgin

Director of the Center for the Development of Therapeutics, Broad Institute of MIT and Harvard

Lisa Carnell

Program Scientist for Translational Research

Steven Chinowsky

Partner

Twyman Clements

Co-Founder and CEO

John Connolly

Chief Scientific Officer

Neils Emmerich

VP Global Head, Search & Evaluation

Kevin Engelbert

Manager, In Space Production Applications

Dan Estes, PhD

General Partner, Frazier Healthcare Partners

Jason Fenton

Managing Director, Equity Capital Markets

Angus Grant

Chief Business Executive, BeiGene

David Greenwald

Vice President, Business Development, Deerfield Management

Jason Hafler

Managing Director, Sanofi Ventures

Nancy Hong

Managing Director

John Hood

Founder, CEO and Executive Chairman

Lila Hope

Partner

Catriona Jamieson, MD, Ph.D.

Director, Sanford Stem Cell Institute

Ash Khanna

Partner, Pivotal bioVenture Partners

Rachna Khosla

Senior Vice President, Business Development

Nina Kjellson

General Partner

Jim Krenn

Partner, Morrison Foerster

Angela Kujak

Head of Legal Office of Strategic Alliances and Partnerships

Jennifer Leeds

Executive Director, Head NIBR BD&L Search and Evaluation, West Coast and Canada, Novartis

Jay Lichter

Managing Director, Avalon Ventures; President and CEO, Arialys Therapeutics

Tim Luker

Vice President, Venture Science, West Coast USA Head, Corp BD

Christian Maender

Executive Vice President, In-Space Solutions

Patty Maysent

CEO

Grace Han McMahon

AVP and Head, Pacific BD&L, Merck

Detlev Mennerich

Corporate SVP, Global Head of Business Development & Licensing, Boehringer Ingelheim

Imran Nasrullah

VP & Head, Collaborate2Cure Hub, US, BD&L

Vern Norviel

Partner, Patents and Innovation

Carole Nuechterlein

Head, Roche Venture Fund

Michael Palladinetti

Global Head of Business Development & Licensing

Joseph Panetta

President and CEO, Biocom California

Mark Paris

Executive Director, Oncology Search and Evaluation

Scott Platshon

Partner

Jeremy Quirk

VP BD&L Commercial Portfolio

Visali Ramanathan

Senior Director, Business Development

John Reed

EVP, Global Head of R&D

Alicia Russo

Partner, Co-Chair, Venable’s Intellectual Property Transactions Group

Camille Samuels

Partner, Venrock

Andy Schwab

Founder and Managing Partner, 5AM Ventures

Arun Sharma, PhD

Assistant Professor, Board of Governors Regenerative Medicine Institute, Smidt Heart Institute

Ken Shields

Sr. Director, Business Development

Deborah Smith

Partner, Patent and Innovations

Tari Suprapto

Director, Search & Evalutation (West), Novo Nordisk

Matt Tremblay, Ph.D.

Chief Operating Officer, The Scripps Research Institute & Calibr

Issei Tsukamoto

SVP, Head of Business Development

Daniel Tumas

VP, Head of Search and Evaluation

Court Turner

Partner

D.A. Wallach

General Partner, Co-Founder, Time BioVentures

Asish Xavier

Vice President, Venture Investments